We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Biomarkers Suggest Dieting Alternatives for Longevity

By Biotechdaily staff writers
Posted on 13 Aug 2002
A study on aging has revealed that men with lower body temperatures, lower blood insulin levels, and higher blood levels of dehydroepiandrosterone sulfate (DHEAS) as they aged tended to live longer without reducing calories, and that monkeys with these characteristics lived longer if their caloric intake was severely restricted. More...
These findings were reported in the August 2, 2002, issue of Science.

Investigators from the US National Institute of Aging (Bethesda, MD, USA) compared more than 700 healthy men, aged 19 to 95, with 60 rhesus monkeys, aged five to 25. The men were divided into two groups, based on whether they were in the upper or lower halves of the population for each of the three biomarkers--body temperature, blood insulin levels, and blood levels of DHEAS. The monkeys also were divided into two groups. One group was allowed to feed freely, typically consuming between 500 to 1,000 calories daily. A second group was fed a diet composed of at least 30% fewer calories than consumed by the unrestricted monkeys.

Biomarker and mortality data were collected on the men over a 25-year period, and biomarker data were gathered on the monkeys for five years beginning in 1987. Deaths among the monkeys have been tracked for more than 15 years.

Analysis of age-adjusted data revealed that among the participating men, those who had lower body temperatures, lower blood insulin levels, and higher blood levels of DHEAS as they aged tended to live longer. The calorically restricted monkeys showed a similar trend, and had half the death rate of monkeys allowed to feed freely.

None of the men, who reported consuming an average of 2,300 calories daily, was on a calorically restricted diet. "The fact that these men apparently were not practicing caloric restriction is important because it means there may be other ways to achieve biological hallmarks without having to undergo drastic dietary changes,” said Dr. George Roth, senior guest scientist at NIA and lead author of the study. "Although we do not yet know what these pathways are, this finding suggests it may be possible to develop compounds that offer the benefits of caloric restriction without having to resort to it.”




Related Links:
NIH/National Institute on Aging

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Platelet Function Analyzer
PL-12
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Automatic CLIA Analyzer
Shine i6000
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Dr. Olivia Belbin, head of the Molecular Neurodegeneration Group at IR Sant Pau and study corresponding author, with Alba Cervantes (right), first author and IR Sant Pau researcher (Photo courtesy of IR Sant Pau)

Blood Biomarker Detects Alzheimer’s Changes Decades Before Symptoms in Down Syndrome

Alzheimer’s disease can begin altering the brain long before clinical symptoms appear, creating a challenge for early-stage detection and research. People with Down syndrome face a particularly high age-related... Read more

Molecular Diagnostics

view channel
Photo courtesy of National Human Genome Research Institute

Genomic Screening Expands Detection of Treatable Conditions in Newborns

Conventional newborn screening can miss conditions that lack biochemical biomarkers or present atypically. Initial hearing screens may also fail to detect hearing loss that is later identified through... Read more

Microbiology

view channel
Image: Invasive aspergillosis (IA) is a potentially life-threatening infection caused by Aspergillus mold that primarily affects people with severely weakened immune systems. (Image Credit: Adobe Stock)

Rapid Urine Test Aids Diagnosis of Invasive Aspergillosis

Invasive aspergillosis is an uncommon mold infection in the general population but can pose serious risks for people with weakened immune defenses. Diagnosis can be difficult because existing approaches... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image: NMPA approvals for Quanterix HD-X and SR-X instruments and four neurology biomarker assays expand access to ultrasensitive blood-based testing in China (Photo courtesy of Quanterix Corporation)

Regulatory Milestone Expands Access to Blood-Based Neurology Biomarker Testing in China

Quanterix Corporation (Billerica, MA, USA) and Innovita Biological Technology Co., Ltd. (Beijing, China) announced regulatory approvals that expand access to Quanterix SIMOA technology and neurology biomarker... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.